Chronic obstructive pulmonary disease management: the evidence base.

Area of Science:

• Pulmonary Medicine
• Respiratory Health

Background:

• Stable chronic obstructive pulmonary disease (COPD) management often involves medications that improve pulmonary function tests.
• However, substantial evidence linking these drug therapies to improved long-term clinical outcomes in COPD is scarce.
• Symptom relief, particularly dyspnea reduction, remains a primary indication for treatment.

Purpose of the Study:

• To review the evidence for interventions in stable COPD and acute exacerbations.
• To highlight therapies with strong evidence for improving long-term outcomes and symptom management.

Main Methods:

• Literature review of evidence for COPD management strategies.
• Analysis of studies focusing on stable COPD and acute exacerbations.

Main Results:

• Oxygen therapy is strongly evidenced for chronically hypoxemic COPD patients.
• Pulmonary rehabilitation improves exercise tolerance and dyspnea in stable COPD.
• Inhaled corticosteroids benefit patients with frequent exacerbations.
• Bronchodilators and corticosteroids shorten COPD exacerbation duration and severity.
• Antibiotics and noninvasive ventilation are beneficial in acute COPD exacerbations.

Conclusions:

• While many COPD treatments improve lung function, robust evidence for long-term outcome improvement is limited for some.
• Oxygen therapy, pulmonary rehabilitation, inhaled corticosteroids, and acute exacerbation treatments (bronchodilators, corticosteroids, antibiotics, noninvasive ventilation) have significant clinical support.